ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för Yosprala. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2017-02-23

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.

Zhang W, Han Y, Fort JG, Schofield D, Tursi JP.

J Med Econ · journal article · DOI 10.1080/13696998.2017.1289940

Bibliografisk träff 2017-01-01

Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.

Sharma T, Bliden K, Chaudhary R, Tantry U, Gurbel PA.

Expert Opin Pharmacother · review; journal article · DOI 10.1080/14656566.2016.1269747

Bibliografisk träff 2017-01-01

Yosprala - a combination of aspirin and omeprazole.

Författaruppgift saknas

Med Lett Drugs Ther · review; journal article

Bibliografisk träff 2016-08-01

Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.

Goldstein JL, Scheiman JM, Fort JG, Whellan DJ.

J Cardiovasc Pharmacol · randomized controlled trial; journal article · DOI 10.1097/fjc.0000000000000387

Bibliografisk träff 2016-04-01

Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.

Goldstein JL, Whellan DJ, Scheiman JM, Cryer BL, Eisen GM, Lanas A, Fort JG.

Cardiovasc Ther · clinical trial, phase iii; research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/1755-5922.12172

Bibliografisk träff 2014-10-10

PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.

Duffy D, Rooney B, Adams S, Whellan DJ.

Expert Rev Cardiovasc Ther · other; research support, non-u.s. gov't; review; journal article · DOI 10.1586/14779072.2014.967214

Bibliografisk träff 2014-06-09

PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.

Whellan DJ, Goldstein JL, Cryer BL, Eisen GM, Lanas A, Miller AB, Scheiman JM, Fort JG, Zhang Y, O'Connor C.

Am Heart J · clinical trial, phase iii; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.ahj.2014.05.017

Bibliografisk träff 2014-03-01

Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.

Toth P, Bernd R.

Rev Bras Reumatol · journal article; case reports · DOI 10.1016/j.rbr.2014.03.011

Bibliografisk träff 2013-11-01

PA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.

Bliden KP, Brener M, Gesheff MG, Franzese CJ, Tabrizchi A, Tantry U, Gurbel PA.

Future Cardiol · review; journal article · DOI 10.2217/fca.13.67

Bibliografisk träff 2013-05-21

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.

Miner PB, Fort JG, Zhang Y.

Aliment Pharmacol Ther · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1111/apt.12340

Bibliografisk träff 2012-12-04

Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.

Gurbel PA, Bliden KP, Fort JG, Jeong YH, Shuldiner A, Chai S, Gesheff T, Antonino M, Gesheff M, Zhang Y, Tantry US.

Am Heart J · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.ahj.2012.07.032

Bibliografisk träff 2011-11-02

Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study.

Gurbel PA, Bliden KP, Fort J, Zhang Y, Plachetka JR, Antonino M, Gesheff M, Tantry US.

Clin Pharmacol Ther · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1038/clpt.2011.201

Bibliografisk träff 2007-10-26

Reversible hearing loss in temporal association with chemoprophylactic mefloquine use.

Wise M, Toovey S.

Travel Med Infect Dis · journal article; case reports · DOI 10.1016/j.tmaid.2007.08.006